A citation-based method for searching scientific literature

Fabio A Zucca, Juan Segura-Aguilar, Emanuele Ferrari, Patricia Muñoz, Irmgard Paris, David Sulzer, Tadeusz Sarna, Luigi Casella, Luigi Zecca. Prog Neurobiol 2017
Times Cited: 265







List of co-cited articles
1074 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The role of iron in brain ageing and neurodegenerative disorders.
Roberta J Ward, Fabio A Zucca, Jeff H Duyn, Robert R Crichton, Luigi Zecca. Lancet Neurol 2014
610
17

The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging.
Luigi Zecca, Antonella Stroppolo, Alberto Gatti, Davide Tampellini, Marco Toscani, Mario Gallorini, Giuseppe Giaveri, Paolo Arosio, Paolo Santambrogio, Ruggero G Fariello,[...]. Proc Natl Acad Sci U S A 2004
280
15

New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals.
Luigi Zecca, Chiara Bellei, Patrizia Costi, Alberto Albertini, Enrico Monzani, Luigi Casella, Mario Gallorini, Luigi Bergamaschi, Alberto Moscatelli, Nicholas J Turro,[...]. Proc Natl Acad Sci U S A 2008
119
12

Ferroptosis: an iron-dependent form of nonapoptotic cell death.
Scott J Dixon, Kathryn M Lemberg, Michael R Lamprecht, Rachid Skouta, Eleina M Zaitsev, Caroline E Gleason, Darpan N Patel, Andras J Bauer, Alexandra M Cantley, Wan Seok Yang,[...]. Cell 2012
12


Iron, brain ageing and neurodegenerative disorders.
Luigi Zecca, Moussa B H Youdim, Peter Riederer, James R Connor, Robert R Crichton. Nat Rev Neurosci 2004
11

Neuromelanin of the human substantia nigra: an update.
Fabio A Zucca, Emy Basso, Francesca A Cupaioli, Emanuele Ferrari, David Sulzer, Luigi Casella, Luigi Zecca. Neurotox Res 2014
115
11

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.
D T Dexter, F R Wells, A J Lees, F Agid, Y Agid, P Jenner, C D Marsden. J Neurochem 1989
829
11


Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
D T Dexter, A Carayon, F Javoy-Agid, Y Agid, F R Wells, S E Daniel, A J Lees, P Jenner, C D Marsden. Brain 1991
756
10


Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease.
David Sulzer, Clifford Cassidy, Guillermo Horga, Un Jung Kang, Stanley Fahn, Luigi Casella, Gianni Pezzoli, Jason Langley, Xiaoping P Hu, Fabio A Zucca,[...]. NPJ Parkinsons Dis 2018
78
11

Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease.
Fabio A Zucca, Renzo Vanna, Francesca A Cupaioli, Chiara Bellei, Antonella De Palma, Dario Di Silvestre, Pierluigi Mauri, Sara Grassi, Alessandro Prinetti, Luigi Casella,[...]. NPJ Parkinsons Dis 2018
42
21


Parkinson's disease.
Lorraine V Kalia, Anthony E Lang. Lancet 2015
9

Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease.
Luigi Zecca, Luigi Casella, Alberto Albertini, Chiara Bellei, Fabio A Zucca, Mireille Engelen, Andrzej Zadlo, Grzegorz Szewczyk, Mariusz Zareba, Tadeusz Sarna. J Neurochem 2008
123
9

Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes.
L Zecca, M Gallorini, V Schünemann, A X Trautwein, M Gerlach, P Riederer, P Vezzoni, D Tampellini. J Neurochem 2001
261
9

Staging of brain pathology related to sporadic Parkinson's disease.
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
9

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain.
E Sofic, P Riederer, H Heinsen, H Beckmann, G P Reynolds, G Hebenstreit, M B Youdim. J Neural Transm 1988
557
9


Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease.
Wei Zhang, Kester Phillips, Albert R Wielgus, Jie Liu, Alberto Albertini, Fabio A Zucca, Rudolph Faust, Steven Y Qian, David S Miller, Colin F Chignell,[...]. Neurotox Res 2011
137
8

Oxidative stress and cellular pathologies in Parkinson's disease.
Lesly Puspita, Sun Young Chung, Jae-Won Shim. Mol Brain 2017
158
8

Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour.
L Zecca, D Tampellini, M Gerlach, P Riederer, R G Fariello, D Sulzer. Mol Pathol 2001
111
8

The relevance of iron in the pathogenesis of Parkinson's disease.
Jeswinder Sian-Hülsmann, Silvia Mandel, Moussa B H Youdim, Peter Riederer. J Neurochem 2011
211
8

Targeting chelatable iron as a therapeutic modality in Parkinson's disease.
David Devos, Caroline Moreau, Jean Christophe Devedjian, Jérome Kluza, Maud Petrault, Charlotte Laloux, Aurélie Jonneaux, Gilles Ryckewaert, Guillaume Garçon, Nathalie Rouaix,[...]. Antioxid Redox Signal 2014
295
8

Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains.
P Riederer, E Sofic, W D Rausch, B Schmidt, G P Reynolds, K Jellinger, M B Youdim. J Neurochem 1989
8

Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease.
Benjamin G Trist, Dominic J Hare, Kay L Double. Aging Cell 2019
81
9


Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease.
Deepinder Kaur, Ferda Yantiri, Subramanian Rajagopalan, Jyothi Kumar, Jun Qin Mo, Rapee Boonplueang, Veena Viswanath, Russell Jacobs, Lichuan Yang, M Flint Beal,[...]. Neuron 2003
455
7

Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease.
Lena F Burbulla, Pingping Song, Joseph R Mazzulli, Enrico Zampese, Yvette C Wong, Sohee Jeon, David P Santos, Judith Blanz, Carolin D Obermaier, Chelsee Strojny,[...]. Science 2017
301
7

Iron and dopamine: a toxic couple.
Dominic J Hare, Kay L Double. Brain 2016
109
7

Locus coeruleus volume and cell population changes during Alzheimer's disease progression: A stereological study in human postmortem brains with potential implication for early-stage biomarker discovery.
Panos Theofilas, Alexander J Ehrenberg, Sara Dunlop, Ana T Di Lorenzo Alho, Austin Nguy, Renata Elaine Paraizo Leite, Roberta Diehl Rodriguez, Maria B Mejia, Claudia K Suemoto, Renata Eloah De Lucena Ferretti-Rebustini,[...]. Alzheimers Dement 2017
121
7



Contrast mechanisms associated with neuromelanin-MRI.
Paula Trujillo, Paul E Summers, Emanuele Ferrari, Fabio A Zucca, Michela Sturini, Luca T Mainardi, Sergio Cerutti, Alex K Smith, Seth A Smith, Luigi Zecca,[...]. Magn Reson Med 2017
51
13

Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.
Patrice Péran, Andrea Cherubini, Francesca Assogna, Fabrizio Piras, Carlo Quattrocchi, Antonella Peppe, Pierre Celsis, Olivier Rascol, Jean-François Démonet, Alessandro Stefani,[...]. Brain 2010
274
7

Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
Makoto Sasaki, Eri Shibata, Koujiro Tohyama, Junko Takahashi, Kotaro Otsuka, Kuniaki Tsuchiya, Satoshi Takahashi, Shigeru Ehara, Yasuo Terayama, Akio Sakai. Neuroreport 2006
239
7

Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles.
D Sulzer, J Bogulavsky, K E Larsen, G Behr, E Karatekin, M H Kleinman, N Turro, D Krantz, R H Edwards, L A Greene,[...]. Proc Natl Acad Sci U S A 2000
277
7

Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases.
Matthew J Betts, Evgeniya Kirilina, Maria C G Otaduy, Dimo Ivanov, Julio Acosta-Cabronero, Martina F Callaghan, Christian Lambert, Arturo Cardenas-Blanco, Kerrin Pine, Luca Passamonti,[...]. Brain 2019
77
9

Iron, Myelin, and the Brain: Neuroimaging Meets Neurobiology.
Harald E Möller, Lucia Bossoni, James R Connor, Robert R Crichton, Mark D Does, Roberta J Ward, Luigi Zecca, Fabio A Zucca, Itamar Ronen. Trends Neurosci 2019
33
21

Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry.
Antje Biesemeier, Oliver Eibl, Santhana Eswara, Jean-Nicolas Audinot, Tom Wirtz, Gianni Pezzoli, Fabio A Zucca, Luigi Zecca, Ulrich Schraermeyer. J Neurochem 2016
24
29

Individual dopaminergic neurons show raised iron levels in Parkinson disease.
A E Oakley, J F Collingwood, J Dobson, G Love, H R Perrott, J A Edwardson, M Elstner, C M Morris. Neurology 2007
178
7

Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease.
Brent R Stockwell, José Pedro Friedmann Angeli, Hülya Bayir, Ashley I Bush, Marcus Conrad, Scott J Dixon, Simone Fulda, Sergio Gascón, Stavroula K Hatzios, Valerian E Kagan,[...]. Cell 2017
7


Increased nigral iron content in postmortem parkinsonian brain.
D T Dexter, F R Wells, F Agid, Y Agid, A J Lees, P Jenner, C D Marsden. Lancet 1987
372
7

Oxidative stress in Parkinson's disease.
Peter Jenner. Ann Neurol 2003
6

Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson's disease pathogenesis.
Iria Carballo-Carbajal, Ariadna Laguna, Jordi Romero-Giménez, Thais Cuadros, Jordi Bové, Marta Martinez-Vicente, Annabelle Parent, Marta Gonzalez-Sepulveda, Núria Peñuelas, Albert Torra,[...]. Nat Commun 2019
79
7

Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease.
H Fedorow, F Tribl, G Halliday, M Gerlach, P Riederer, K L Double. Prog Neurobiol 2005
184
6

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.
M A Smith, P L Harris, L M Sayre, G Perry. Proc Natl Acad Sci U S A 1997
933
6

Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI.
Anna I Blazejewska, Stefan T Schwarz, Alain Pitiot, Mary C Stephenson, James Lowe, Nin Bajaj, Richard W Bowtell, Dorothee P Auer, Penny A Gowland. Neurology 2013
159
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.